Regeneron reports fourth quarter and full year 2023 financial and operating results

Tarrytown, n.y., feb. 02, 2024 (globe newswire) -- regeneron pharmaceuticals, inc. (nasdaq: regn) today announced financial results for the fourth quarter and full year 2023 and provided a business update.

REGN Ratings Summary

REGN Quant Ranking